Publications 2023 |
| Ahn YH, Tang Y, Illes P The neuroinflammatory astrocytic P2X7 receptor: Alzheimer s disease, ischemic brain injury, and epileptic state. Expert Opin Ther Targets 2023; 27(9): 763-778 ISSN 1472-8222 Impact factor: 5.8 Behne S, Franke H, Schwarz S, Lachenmeier DW Risk Assessment of Chlorogenic and Isochlorogenic Acids in Coffee By-Products. Molecules 2023; 28(14): 5540 ISSN 1420-3049 Impact factor: 4.6 He JR, Rubini P, Li BM, Yin HY, Tang Y, Illes P Beneficial effect of electroacupuncture on the distribution of foreign substances in the brain of rats developing depression-like behavior. IBRO Neurosci Rep 2023; 14: 398-406 ISSN 2667-2421 Impact factor: 1.5 Himmerich H, Saedisomeolia A, Krügel U Editorial: Community series in extreme eating behaviors-Volume II. Front Psychiatry 2023; 14: 1200098 ISSN 1664-0640 IF: 4.7 Illes P, Ulrich H, Chen JF, Tang Y Purinergic receptors in cognitive disturbances. Neurobiol Dis 2023; 185: 106229 ISSN 0969-9961 Impact factor: 6.1 Jia W, Huang Z, Zhou L, Liou YC, Di Virgilio F, Ulrich H, Illes P, Zhang W, Huang C, Tang Y Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resist Updat 2023; 70: 100988 ISSN 1368-7646 Impact factor: 24.3 Karimov M, Scherer M, Franke H, Ewe A, Aigner A Analysis of polymeric nanoparticle properties for siRNA/DNA delivery in a tumor xenograft tissue slice air-liquid interface model. Biotechnol J 2023; 18(4): 2200415 ISSN 1860-676 IF: 4.7 Kayser C, Melkes B, Derieux C, Bock A Spatiotemporal GPCR signaling illuminated by genetically encoded fluorescent biosensors. Curr Opin Pharmacol 2023; 71: 102384 ISSN 1471-4892 Impact factor: 4.0 Konstantinidis N, Franke H, Schwarz S, Lachenmeier DW Risk Assessment of Trigonelline in Coffee and Coffee By-Products. Molecules 2023; 28(8): 0 ISSN 1420-3049 IF: 4.6 Lin SS, Zhou B, Chen BJ, Jiang RT, Li B, Illes P, Semyanov A, Tang Y, Verkhratsky A Electroacupuncture prevents astrocyte atrophy to alleviate depression. Cell Death Dis 2023; 14(5): 343 ISSN 2041-4889 IF: 9.0 Quentin T, Franke H, Lachenmeier DW Risk Assessment of Isoeugenol in Food Based on Benchmark Dose-Response Modeling. Toxics 2023; 11(12): 991 ISSN 2305-6304 Impact factor: 4.6 Raudszus R, Paulig A, Urban N, Deckers A, Gräßle S, Vanderheiden S, Jung N, Bräse S, Schaefer M, Hill K Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages. Br J Pharmacol 2023; 0: 0 ISSN 0007-1188 IF: 7.3 Ren WJ, Zhao YF, Li J, Rubini P, Yuan ZQ, Tang Y, Illes P P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex. Cereb Cortex 2023; 0: 0 ISSN 1047-3211 IF: 3.7 Shi NR, Wang Q, Liu J, Zhang JZ, Deng BL, Hu XM, Yang J, Wang X, Chen X, Zuo YQ, Liu TT, Zheng JL, Yang X, Illes P, Tang Y Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy. Front Pharmacol 2023; 14: 1152667 ISSN 1663-9812 IF: 5.6 Tang Y, Chen JF, Illes P Editorial: Purinergic signalling - a perspective from China. Purinergic Signal 2023; 19(1): 1-3 ISSN 1573-9538 IF: 3.5 Urban N, Leonhardt M, Schaefer M Multiplex GPCR screen reveals reliably acting agonists and a Gq-phospholipase C coupling mode of GPR30/GPER1. Mol Pharmacol 2023; 103(2): 48-62 ISSN 0026-895X IF: 3.6 Verkhratsky A, Butt A, Li B, Illes P, Zorec R, Semyanov A, Tang Y, Sofroniew MV Astrocytes in human central nervous system diseases: a frontier for new therapies. Signal Transduct Target Ther 2023; 8(1): 396 ISSN 2095-9907 Impact factor: 39.3 Zhang JZ, Shi NR, Wu JS, Wang X, Illes P, Tang Y UDP-glucose sensing P2Y(14)R: A novel target for inflammation. Neuropharmacology 2023; 0: 109655 ISSN 0028-3908 Impact factor: 4.7 Zhao YF, Illes P Adenosine A2A receptor-bearing GABAergic neurons in the lateral septum of the brain: novel mediators of depressive-like behavior. Purinergic Signal 2023; 0: 0 ISSN 1573-9538 IF: bisher wurde noch kein IF ermittelt |